Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$22.62 - $39.32 $205,615 - $357,418
9,090 Added 4.36%
217,705 $5.53 Million
Q1 2023

Apr 26, 2023

BUY
$30.17 - $41.11 $128,675 - $175,334
4,265 Added 2.09%
208,615 $7.54 Million
Q4 2022

Feb 09, 2023

SELL
$36.43 - $49.4 $145,829 - $197,748
-4,003 Reduced 1.92%
204,350 $8.09 Million
Q3 2022

Nov 01, 2022

BUY
$40.66 - $53.03 $37,203 - $48,522
915 Added 0.44%
208,353 $9.71 Million
Q2 2022

Aug 02, 2022

BUY
$40.85 - $77.67 $2.44 Million - $4.64 Million
59,755 Added 40.46%
207,438 $9.09 Million
Q1 2022

May 11, 2022

SELL
$59.95 - $92.06 $9.89 Million - $15.2 Million
-165,001 Reduced 52.77%
147,683 $10.7 Million
Q4 2021

Feb 08, 2022

SELL
$81.07 - $121.29 $5.37 Million - $8.03 Million
-66,217 Reduced 17.48%
312,684 $25.3 Million
Q3 2021

Nov 09, 2021

SELL
$101.99 - $166.36 $3.58 Million - $5.83 Million
-35,074 Reduced 8.47%
378,901 $44.1 Million
Q2 2021

Aug 12, 2021

BUY
$141.6 - $179.06 $8.51 Million - $10.8 Million
60,120 Added 16.99%
413,975 $68.6 Million
Q1 2021

May 11, 2021

BUY
$132.81 - $182.18 $749,978 - $1.03 Million
5,647 Added 1.62%
353,855 $49.4 Million
Q4 2020

Feb 05, 2021

SELL
$138.17 - $184.34 $2.94 Million - $3.92 Million
-21,244 Reduced 5.75%
348,208 $60.3 Million
Q3 2020

Nov 04, 2020

BUY
$114.09 - $145.51 $23.9 Million - $30.5 Million
209,375 Added 130.8%
369,452 $51.5 Million
Q2 2020

Aug 06, 2020

BUY
$89.45 - $129.85 $14.3 Million - $20.8 Million
160,077 New
160,077 $19.1 Million
Q1 2019

May 10, 2019

SELL
$35.52 - $62.62 $14.3 Million - $25.2 Million
-401,681 Closed
0 $0
Q4 2018

Feb 06, 2019

SELL
$35.43 - $56.29 $39 Million - $61.9 Million
-1,099,364 Reduced 73.24%
401,681 $15.6 Million
Q3 2018

Nov 08, 2018

SELL
$44.22 - $75.47 $8.39 Million - $14.3 Million
-189,720 Reduced 11.22%
1,501,045 $85.6 Million
Q2 2018

Aug 02, 2018

BUY
$72.38 - $92.5 $22.3 Million - $28.5 Million
307,980 Added 22.27%
1,690,765 $135 Million
Q1 2018

Apr 20, 2018

BUY
$69.46 - $88.57 $6.94 Million - $8.85 Million
99,911 Added 7.79%
1,382,785 $120 Million
Q4 2017

Jan 25, 2018

BUY
$65.94 - $93.31 $9.49 Million - $13.4 Million
143,962 Added 12.64%
1,282,874 $88.6 Million
Q3 2017

Nov 03, 2017

BUY
$80.87 - $91.08 $92.1 Million - $104 Million
1,138,912
1,138,912 $104 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.